Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis (CRCRT-EC)

This study has been completed.
Information provided by (Responsible Party):
Centre Oscar Lambret Identifier:
First received: January 30, 2012
Last updated: February 1, 2012
Last verified: February 2012
The aim of this study is to identify prognostic factors for outcome in patients being complete clinical responders with chemoradiation or radiation for esophageal cancer

Condition Intervention
Esophageal Cancer
Drug: Chemotherapy
Radiation: Radiotherapy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Predictors of Survival for Complete Clinical Responders to Definite Chemoradiation or Radiation Therapy for Esophageal Cancer

Resource links provided by NLM:

Further study details as provided by Centre Oscar Lambret:

Primary Outcome Measures:
  • Identification of prognostic factors for overall survival [ Time Frame: From date of treatment until death, assessed up to 10 years ]
    Correlation between survival and baseline,clinical and treatment characteristics

Secondary Outcome Measures:
  • Patterns of treatment failure [ Time Frame: From date of treatment until treatment failure, assessed up to 10 years ]
    Type of recurrence : local, regional, distant.

  • Disease-free survival [ Time Frame: From date of treatment until progression or death, assessed up to 10 years ]
    Time between the end of treatment and the occurence of progression

Enrollment: 110
Study Start Date: January 2012
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Chemotherapy
    Chemotherapy according to standard
    Radiation: Radiotherapy
    Radiotherapy according to local standard

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient treated for esophageal cancer in the Northern France Cancer Center from january 1998 to december 2003

Inclusion Criteria:

  • localized or locally advanced esophageal cancer
  • patient who underwent definite chemoradiation or radiation
  • patient with complete clinical response

Exclusion Criteria:

  • metastatic disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01525953

Centre Oscar LAMBRET
Lille, France, 59000
Sponsors and Collaborators
Centre Oscar Lambret
Principal Investigator: Antoine ADENIS, MD, PhD Centre Oscar Lambret
  More Information

Responsible Party: Centre Oscar Lambret Identifier: NCT01525953     History of Changes
Other Study ID Numbers: CRCRT-EC
Study First Received: January 30, 2012
Last Updated: February 1, 2012

Keywords provided by Centre Oscar Lambret:
esophageal cancer

Additional relevant MeSH terms:
Esophageal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Head and Neck Neoplasms
Digestive System Diseases
Esophageal Diseases
Gastrointestinal Diseases processed this record on April 28, 2017